Associate Professor, Medicine, Georgetown University School of Medicine
Nephrology
Dr. Michael S. Lipkowitz, MD
|
|
Give Review
Dr. Michael S. Lipkowitz works in the field of Nephrology. He went to Mount Sinai School of Medicine. He received 1 awards: "Meaningful Use Stage 1 Certification". Michael S. Lipkowitz is a published doctor and has 63 publications published. The lastest was: 'Adeno-associated virus gene transfer into renal cells: potential for in vivo gene delivery.' He is registered with Medicare and accepts Medicare payments.
Publications
- Estimating Time to ESRD Using Kidney Failure Risk Equations: Results From the African American Study of Kidney Disease and Hypertension (AASK).
- What Level of Sodium Intake Worsens Renal Outcomes?
- A Within-Patient Analysis for Time-Varying Risk Factors of CKD Progression.
- APOL1 risk variants, race, and progression of chronic Kidney disease.
- Association of phosphodiesterase 4 polymorphism (rs702553) with blood pressure in the African American Study of Kidney Disease and Hypertension Genomics Study.
- Loss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive Kidney disease in the African American Study of Kidney Disease (AASK).
- Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of Kidney function decline in African Americans.
- Chromogranin A regulates Renal function by triggering Weibel-Palade body exocytosis.
- The role of ambulatory BP monitoring in clinical care.
- How accurate are formulas that calculate creatinine clearance?
- Galectin 9 is the sugar-regulated urate transporter/channel UAT.
- Functional analysis and molecular model of the human urate transporter/channel, hUAT.
- Polarity of alpha-galactosidase A uptake by Renal tubule cells.
- Heritable Influence of DBH on Adrenergic and Renal Function: Twin and Disease Studies.
- Limitations of analyses based on achieved blood pressure: lessons from the African American study of Kidney disease and hypertension trial.
- Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Diseas...
- Genetic association and gene-gene interaction analyses in African American dialysis patients With nondiabetic nephropathy.
- Association of a CYP4A11 variant and blood pressure in black men.
- Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic Kidney disease in African Americans.
- G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.
- Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in Hypertensive nephrosclerosis.
- CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women With early hypertensive renal disease.
- CRP polymorphisms and progression of chronic Kidney disease in African Americans.
- Progression of chronic Kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis.
- Intensive blood-pressure control in hypertensive chronic Kidney disease.
- Common charge-shift mutation Glu65Lys in K+ channel βâ-Subunit KCNMB1: pleiotropic consequences for glomerular filtration rate and progressive Renal disease.
- Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.
- Uric acid transport.
- Localization and topology of a urate transporter/channel, a galectin, in epithelium-derived cells.
- Altered membrane ionic permeability in a rat model of chronic renal Failure.
- Hormonal regulation of rat Renal proximal tubule brush-border membrane ionic permeability.
- Ontogeny of Na/H antiporter activity in rabbit Renal brush border membrane vesicles.
- Modulation of the ionic permeability of Renal cortical brush-border membranes by cAMP.
- Modulation of ionic permeability in a nonpolarized cell: effect of cAMP.
- Differential permeabilities of rat Renal brush-border and basolateral membrane vesicles.
- Cl-/HCO-3 antiporter in red cell ghosts: a kinetic assessment With fluorescent probes.
- Characterization of the fetal glucose transporter in rabbit Kidney. Comparison with the adult brush border electrogenic Na+-glucose symporter.
- Ionic permeabilities of rat Renal cortical brush-border membrane vesicles.
- Evidence for the transport function of uricase, an oxidative enzyme.
- Carrier-mediated concentrative urate transport in rat Renal membrane vesicles.
- Isolation and immunolocalization of a rat Renal cortical membrane urate transporter.
- Developmental changes of Renal brushborder membrane ionic permeability.
- Hormonal modulation of ionic permeability in human red blood cells.
- Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated With left ventricular mass and geometric remodeling in systemic hypertension.
- Molecular therapy for renal Diseases.
- Glycogen synthase polymorphism, insulin resistance and Hypertension.
- Adeno-associated virus gene transfer into Renal cells: potential for in vivo gene delivery.
- Transduction of Renal cells in vitro and in vivo by adeno-associated virus gene therapy vectors.
- Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter.
- β(1)-adrenergic receptor polymorphisms and response to β-blockade in the African-American study of Kidney disease and hypertension (AASK).
- Routine use of ambulatory blood pressure monitoring in potential living Kidney donors.
- Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study.
- Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter.
- Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive Kidney disease.
- Liposome-mediated transfer of nitric oxide synthase gene improves Renal function in ureteral obstruction in rats.
- The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of Kidney disease and hypertension.
- Preventing renal dysfunction in patients With hypertension: clinical implications from the early AASK Trial results.
- The rationale and design of the AASK cohort study.
- Blood pressure control, drug therapy, and Kidney disease.
- Adeno-associated viral vector transduction of green fluorescent protein in Kidney: effect of unilateral ureteric obstruction.
- Effect of ramipril vs amlodipine on Renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
- Malnutrition-inflammation modifies the relationship of cholesterol With cardiovascular disease.
Schools
SUNY Downstate Medical Center College Of Medicine
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Calcium Metabolism Disorders
- Chronic Glomerulonephritis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
Mount Sinai School of Medicine -
State University of New York Downstate Medical Center College of Medicine
Hospital
-
MedStar Georgetown University Hospital
Drug Facts
| NPI NUMBER | 1902824725 | |
| NPPES Provider LastName | LIPKOWITZ | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 200072113 | |
| NPPES Provider State | DC | |
| Specialty Description | Nephrology | |
| Total Claim Count | 506.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1902824725 |
| Last Name Of The Provider | LIPKOWITZ |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Xiaoru Yang, MD |
|
|
Dr. Christopher S. Wilcox, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jason Umans, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Robert Rubin, MD |
|
|
Dr. Chanigan Nilubol, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nabeel M. Imam, MD |
|
|
Dr. Shakil Aslam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fred I. Polsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Usman J. Rahmat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Basit Javaid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Atul Katyal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Khosrow Davachi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Haobo Zhou, MD |
|
|
Dr. Reginald H. Joseph, MD |